Schedule 13G ownership disclosure
BriaCell Therapeutics Corp.
Common Shares, no par value · CUSIP: 107930208
Event date: 2025-07-15
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Iroquois Capital Management, LLC
Shares: 560,000.00 · Class: 3.2%
- Richard Abbe
Shares: 1,600,000.00 · Class: 9.1%
- Kimberly Page
Shares: 560,000.00 · Class: 3.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000930413-25-002258
- Form type
- SCHEDULE 13G
- Filer
- BriaCell Therapeutics Corp.
- CIK
- CIK 1610820
- Filed
- Jul 28, 2025
- Reporting period
- Jul 15, 2025
- Description
- Schedule 13G beneficial ownership